Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bipolar Disorder01:30

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Bulimia Nervosa01:30

Bulimia Nervosa

Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
Personality Disorders: Schizotypal and Histrionic01:20

Personality Disorders: Schizotypal and Histrionic

Schizotypal personality disorder and histrionic personality disorder are two distinct psychological conditions classified under personality disorders, each characterized by unique behavioral patterns and social difficulties. Both disorders significantly affect interpersonal relationships and emotional well-being, leading to social isolation and frustration.
Schizotypal Personality Disorder: Eccentric Behavior and Social Withdrawal
Schizotypal personality disorder is marked by odd or eccentric...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Community-based psychosocial interventions using mother-baby singing groups reduce symptoms of postpartum depression.]

Recenti progressi in medicina·2026
Same author

An evaluation of designs for Phase I/IIa dose-finding studies in Tuberculosis.

Statistical methods in medical research·2026
Same author

Factors associated with depression among people with cancer: Systematic umbrella review.

Palliative & supportive care·2026
Same author

Cost-Effectiveness of Transcranial Magnetic Stimulation and Virtual Reality-Based Cognitive Remediation for Depressive Symptoms among Cancer Patients: Protocol for a Three-Arm Randomized Controlled Trial.

Clinical practice and epidemiology in mental health : CP & EMH·2026
Same author

Presynaptic dopaminergic imaging as a neurodegeneration staging biomarker in the alpha-synucleinopathy continuum.

European journal of nuclear medicine and molecular imaging·2026
Same author

A qualitative study of the impact of the World Health Organisation QualityRights human rights and mental health Training on changing attitudes to mental health and human rights in Ghana.

Frontiers in health services·2026

Related Experiment Video

Updated: May 21, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Bipolar disorders and Wilson's disease.

Mauro Giovanni Carta1, Orazio Sorbello, Maria Francesca Moro

  • 1University of Cagliari, Italy, Cagliari, Italy. mgcarta@tiscali.it

BMC Psychiatry
|June 1, 2012
PubMed
Summary

Wilson's disease (WD) patients show a significantly higher risk for Bipolar Disorder (BD), with an 12.9 times greater prevalence. This association impacts Quality of Life (QL) in WD patients, highlighting a critical link between these conditions.

More Related Videos

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
06:52

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Published on: April 28, 2023

Related Experiment Videos

Last Updated: May 21, 2026

Developing a Rat Model for Bipolar Disorder
04:42

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
06:52

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Published on: April 28, 2023

Area of Science:

  • Neurology
  • Psychiatry
  • Genetics

Background:

  • Wilson's disease (WD) is a rare genetic disorder of copper metabolism.
  • The psychiatric manifestations of WD are diverse and can mimic other mental health conditions.
  • Previous studies have reported psychosis in WD but lacked specific focus on Bipolar Disorder (BD).

Purpose of the Study:

  • To investigate the prevalence of Bipolar Disorder (BD) in patients with Wilson's disease (WD).
  • To assess the impact of BD on Quality of Life (QL) in WD patients.
  • To utilize standardized diagnostic tools for accurate psychiatric assessment in WD.

Main Methods:

  • A case control study design was employed.
  • 23 WD patients and 92 matched controls were included.
  • Psychiatric diagnoses (DSM-IV) and QL (SF-12) were assessed using structured interviews and standardized questionnaires.

Main Results:

  • WD patients exhibited significantly lower QL scores (SF-12) compared to controls.
  • A higher lifetime prevalence of major depressive disorders (OR=5.7) and Bipolar Disorder (OR=12.9) was observed in WD patients.
  • BD was strongly associated with diminished QL in WD patients.

Conclusions:

  • This study provides the first evidence linking Bipolar Disorder (BD) and Wilson's disease (WD) using standardized diagnostic methods.
  • Findings may explain previously reported behavioral changes in WD, such as emotional dysregulation and irritability.
  • The study underscores the importance of screening for BD in WD patients to improve patient outcomes and QL.